Answers are grounded in this paper and cite their sources.
To our knowledge, this individual patient data meta-analysis represents the most comprehensive analysis of the benefits of and adverse events associated with SSTR-targeted PRRT for treatment-refractory meningioma. The treatment was well tolerated, achieved disease control in most cases, and showed promising results regarding PFS and OS.
No takes yet. Share an insight, caveat, or question.
Mirian et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: